Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Local TReatment Patterns and Outcomes With upAdacitinib in IBD Patients in Belgium

NCT06581042 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06581042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Local TReatment Patterns and Outcomes With upAdacitinib in IBD Patients in Belgium
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
September 27, 2024
Completion date
September 30, 2029
Enrollment
280 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease, ulcerative colitis